Subscribe
istock-866149824natee-meepian
Natee Meepian / iStockphoto.com
12 November 2018Africa

Hikma and Vectura collaborate to develop GSK generics

Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Hikma launches generic Xeloda in the US
21 July 2016   Hikma Pharmaceuticals announced yesterday that its US affiliate West-Ward Pharmaceuticals, has launched a generic version of Genentech’s cancer treatment drug Xeloda in the US.
Big Pharma
GSK awarded Arrow declaration in patent dispute with Vectura
17 December 2018   The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Hikma launches generic Xeloda in the US
21 July 2016   Hikma Pharmaceuticals announced yesterday that its US affiliate West-Ward Pharmaceuticals, has launched a generic version of Genentech’s cancer treatment drug Xeloda in the US.
Big Pharma
GSK awarded Arrow declaration in patent dispute with Vectura
17 December 2018   The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.

More on this story

Americas
Hikma launches generic Xeloda in the US
21 July 2016   Hikma Pharmaceuticals announced yesterday that its US affiliate West-Ward Pharmaceuticals, has launched a generic version of Genentech’s cancer treatment drug Xeloda in the US.
Big Pharma
GSK awarded Arrow declaration in patent dispute with Vectura
17 December 2018   The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.

More features

Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages
Judge denies Intellia bid to throw out suit over $100m Regeneron pact